These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11013359)

  • 81. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
    Kumari R; Li H; Haudenschild DR; Fierro F; Carlson CS; Overn P; Gupta L; Gupta K; Nolta J; Yik JH; Di Cesare PE
    Carcinogenesis; 2012 Nov; 33(11):2076-83. PubMed ID: 22847180
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma.
    Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
    J Cancer Res Clin Oncol; 1999 Oct; 125(10):541-8. PubMed ID: 10473866
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma.
    Pan LH; Beppu T; Kurose A; Yamauchi K; Sugawara A; Suzuki M; Ogawa A; Sawai T
    Neurol Res; 2002 Oct; 24(7):677-83. PubMed ID: 12392205
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
    Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
    Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
    [TBL] [Abstract][Full Text] [Related]  

  • 85. CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL).
    Vorwerk P; Wex H; Hohmann B; Oh Y; Rosenfeld RG; Mittler U
    Br J Cancer; 2000 Sep; 83(6):756-60. PubMed ID: 10952780
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
    Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
    PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Intracellular cholesterol biosynthesis in enchondroma and chondrosarcoma.
    Zhang H; Wei Q; Tsushima H; Puviindran V; Tang YJ; Pathmanapan S; Poon R; Ramu E; Al-Jazrawe M; Wunder J; Alman BA
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039139
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gene expression of connective tissue growth factor (CTGF/CCN2) in calcifying tissues of normal and cbfa1-null mutant mice in late stage of embryonic development.
    Yamaai T; Nakanishi T; Asano M; Nawachi K; Yoshimichi G; Ohyama K; Komori T; Sugimoto T; Takigawa M
    J Bone Miner Metab; 2005; 23(4):280-8. PubMed ID: 15981023
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis.
    Shimo T; Nakanishi T; Nishida T; Asano M; Sasaki A; Kanyama M; Kuboki T; Matsumura T; Takigawa M
    Oncology; 2001; 61(4):315-22. PubMed ID: 11721179
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Prognostic significance of p53, HER-2/neu, Ki-67 and VEGF expression in chondrosarcomas].
    Stepanova EV; Kharatishvili TK; Lichinitser MR; Baryshnikov AIu; Solov'ev IuN; Trapeznikov NN
    Arkh Patol; 2002; 64(6):9-12. PubMed ID: 12534219
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
    Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias.
    Aigner T; Frischholz S; Dertinger S; Beier F; Girkontaité I; von der Mark K
    Histochem Cell Biol; 1997 Jun; 107(6):435-40. PubMed ID: 9243276
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
    J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
    [TBL] [Abstract][Full Text] [Related]  

  • 94. CTGF/Hcs24 interacts with the cytoskeletal protein actin in chondrocytes.
    Yosimichi G; Kubota S; Hattori T; Nishida T; Nawachi K; Nakanishi T; Kamada M; Takano-Yamamoto T; Takigawa M
    Biochem Biophys Res Commun; 2002 Dec; 299(5):755-61. PubMed ID: 12470643
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Immunohistochemical localization of connective tissue growth factor (CTGF) in the mouse embryo between days 7.5 and 14.5 of gestation.
    Surveyor GA; Brigstock DR
    Growth Factors; 1999; 17(2):115-24. PubMed ID: 10595311
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Novel enzyme-linked immunosorbent assay systems for the quantitative analysis of connective tissue growth factor (CTGF/Hcs24/CCN2): detection of HTLV-I tax-induced CTGF from a human carcinoma cell line.
    Kawaki H; Kubota S; Minato M; Moritani NH; Hattori T; Hanagata H; Kubota M; Miyauchi A; Nakanishi T; Takigawa M
    DNA Cell Biol; 2003 Oct; 22(10):641-8. PubMed ID: 14611685
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Diagnostic role of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in patients with enchondroma and low-grade chondrosarcoma.
    Yapar A; Ulucaköy C; Sezgin EA; Atalay İB; Ekşioğlu MF
    Jt Dis Relat Surg; 2020; 31(2):286-290. PubMed ID: 32584727
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Elevated levels of Dickkopf-1 are associated with β-catenin accumulation and poor prognosis in patients with chondrosarcoma.
    Chen C; Zhou H; Zhang X; Ma X; Liu Z; Liu X
    PLoS One; 2014; 9(8):e105414. PubMed ID: 25144498
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Nasal chondrogenic tumors: Case reports of primary chondroma and recurrence of atypical cartilaginous tumor (chondrosarcoma grade I) with review of the literature.
    Giotakis AI; Yiotakis I; Mellou A; Koufopoulos N; Giotakis EI
    Indian J Cancer; 2023; 60(2):248-252. PubMed ID: 37530248
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Distinct Roles of Glutamine Metabolism in Benign and Malignant Cartilage Tumors With IDH Mutations.
    Zhang H; Puviindran V; Nadesan P; Ding X; Shen L; Tang YJ; Tsushima H; Yahara Y; Ban GI; Zhang GF; Karner CM; Alman BA
    J Bone Miner Res; 2022 May; 37(5):983-996. PubMed ID: 35220602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.